Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Letter to the Editor: Concepts and methods when considering negative symptom course: a reply.

Savill M, Priebe S.

Psychol Med. 2015 Aug;45(11):2459-60. doi: 10.1017/S0033291715000306. Epub 2015 Apr 28. No abstract available.

PMID:
25919939
2.

Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data.

Savill M, Banks C, Khanom H, Priebe S.

Psychol Med. 2015 Jun;45(8):1613-27. doi: 10.1017/S0033291714002712. Epub 2014 Nov 26.

PMID:
25425086
3.

A pragmatic randomised controlled trial of dialectical behaviour therapy: effects on hospitalisation and post-treatment follow-up.

Barnicot K, Savill M, Bhatti N, Priebe S.

Psychother Psychosom. 2014;83(3):192-3. doi: 10.1159/000357365. Epub 2014 Apr 17. No abstract available.

PMID:
24752222
4.

Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial.

Priebe S, Savill M, Reininghaus U, Wykes T, Bentall R, Lauber C, McCrone P, Röhricht F, Eldridge S.

BMC Psychiatry. 2013 Jan 14;13:26. doi: 10.1186/1471-244X-13-26.

5.

Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review.

Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S.

Clin Psychol Rev. 2012 Jul;32(5):400-12. doi: 10.1016/j.cpr.2012.04.004. Epub 2012 May 1. Review.

PMID:
22681913
6.

Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users' perspectives.

Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S.

PLoS One. 2012;7(5):e36517. doi: 10.1371/journal.pone.0036517. Epub 2012 May 17.

7.

Symptom levels and initial appraisal of hospital treatment in patients with schizophrenia.

Savill M, Jankovic J, Katsakou C, Kallert T, Priebe S.

Psychiatry Res. 2012 Sep 30;199(2):79-83. doi: 10.1016/j.psychres.2012.04.011. Epub 2012 May 5.

PMID:
22565214
8.

Preliminary development and validation of a real-time reverse transcription PCR assay for the semi-quantification of viable Campylobacter jejuni in water samples.

Lin S, Gilpin B, Scholes P, Podivinsky E, Klena J, Savill M.

Water Sci Technol. 2009;60(12):3151-8. doi: 10.2166/wst.2009.811.

PMID:
19955638
9.

Comparison of Campylobacter jejuni genotypes from dairy cattle and human sources from the Matamata-Piako District of New Zealand.

Gilpin BJ, Thorrold B, Scholes P, Longhurst RD, Devane M, Nicol C, Walker S, Robson B, Savill M.

J Appl Microbiol. 2008 Nov;105(5):1354-60. doi: 10.1111/j.1365-2672.2008.03863.x. Epub 2008 Aug 18.

PMID:
18713290
10.

Molecular detection of norovirus in sheep and pigs in New Zealand farms.

Wolf S, Williamson W, Hewitt J, Lin S, Rivera-Aban M, Ball A, Scholes P, Savill M, Greening GE.

Vet Microbiol. 2009 Jan 1;133(1-2):184-9. doi: 10.1016/j.vetmic.2008.06.019. Epub 2008 Jul 5.

PMID:
18676104
11.

The transmission of thermotolerant Campylobacter spp. to people living or working on dairy farms in New Zealand.

Gilpin BJ, Scholes P, Robson B, Savill MG.

Zoonoses Public Health. 2008 Sep;55(7):352-60. doi: 10.1111/j.1863-2378.2008.01142.x.

PMID:
18667028
12.

The seasonality of human cryptosporidiosis in New Zealand.

Lake IR, Pearce J, Savill M.

Epidemiol Infect. 2008 Oct;136(10):1383-7. Epub 2007 Dec 4.

13.

Statistical comparison of Campylobacter jejuni subtypes from human cases and environmental sources.

Garrett N, Devane ML, Hudson JA, Nicol C, Ball A, Klena JD, Scholes P, Baker MG, Gilpin BJ, Savill MG.

J Appl Microbiol. 2007 Dec;103(6):2113-21.

PMID:
18045395
14.

Microbial groundwater quality and its health implications for a border-strip irrigated dairy farm catchment, South Island, New Zealand.

Close M, Dann R, Ball A, Pirie R, Savill M, Smith Z.

J Water Health. 2008 Mar;6(1):83-98.

PMID:
17998609
15.

Environment arrays: a possible approach for predicting changes in waterborne bacterial disease potential.

Heinemann JA, Rosén H, Savill M, Burgos-Caraballo S, Toranzos GA.

Environ Sci Technol. 2006 Dec 1;40(23):7150-6.

PMID:
17180961
16.

Evaluation of uncertainty in quantitative real-time PCR.

Love JL, Scholes P, Gilpin B, Savill M, Lin S, Samuel L.

J Microbiol Methods. 2006 Nov;67(2):349-56. Epub 2006 Jun 2.

PMID:
16735069
17.

The occurrence of Campylobacter subtypes in environmental reservoirs and potential transmission routes.

Devane ML, Nicol C, Ball A, Klena JD, Scholes P, Hudson JA, Baker MG, Gilpin BJ, Garrett N, Savill MG.

J Appl Microbiol. 2005;98(4):980-90.

PMID:
15752345
18.

The use of chemical and molecular microbial indicators for faecal source identification.

Gilpin B, James T, Nourozi F, Saunders D, Scholes P, Savill M.

Water Sci Technol. 2003;47(3):39-43.

PMID:
12639003
19.

Elucidation of potential transmission routes of Campylobacter in New Zealand.

Savill M, Hudson A, Devane M, Garrett N, Gilpin B, Ball A.

Water Sci Technol. 2003;47(3):33-8.

PMID:
12639002
20.

Identification of the source of faecal pollution in contaminated rivers.

Glipin BJ, Gregor JE, Savill MG.

Water Sci Technol. 2002;46(3):9-15.

PMID:
12227609
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk